Treatment of Post-COVID-19 Telogen Effluvium
May 2021
New to Minoxidil? There is a guide in the encyclopedia. Read the guide → 
Studysummary In this study, a case of post-COVID telogen effluvium was reported in which fever and stress following COVID-19 triggered temporary hair loss, and topical treatment showed positive results in improving this condition.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document details a case study of a 34-year-old female patient who experienced post-COVID-19 telogen effluvium, a condition of increased hair loss, particularly in the bitemporal region, which began three months after her COVID-19 infection. The study attributes the hair loss to fever and stress related to COVID-19, with no significant abnormalities found in laboratory tests. The patient was successfully treated with nightly applications of topical Minoxidil 5% for five months, leading to reduced hair loss. The study concludes that topical treatments like Minoxidil are effective for hair loss due to post-COVID-19 telogen effluvium and highlights the importance of addressing the underlying cause.
